Partnering

Boehringer Ingelheim (BI) and Autifony Therapeutics, a Verona, Italy-headquartered spin-out from GlaxoSmithKline, have signed an agreement for acquiring certain aspects of Autifony’s voltage-gated potassium channel modulator platform. BI has obtained…

Novo Nordisk and reMYND, a spin-off contract research organization from the University of Leuven in Belgium, have signed a license agreement to further develop reMYND’s ReS39, a therapeutic for treating…

Aprecia Pharmaceuticals, a Langhorne, Pennsylvania-based specialty pharmaceutical company with a three-dimensional printing (3DP) platform, and Cycle Pharmaceuticals, a Cambridge, England-based pharmaceutical company, have signed a partnership agreement to develop and…

Plasticell, a Stevenage, UK-based developer of stem-cell technologies and cell therapies, has partnered with Anthony Nolan, a research organization for blood cancers, to progress clinical development of Plasticell’s ex vivo…

Amgen and Carmot Therapeutics, a Berkeley, California-headquartered biotechnology company, have entered into a multi-year drug discovery collaboration and licensing agreement. As part of the agreement, Carmot will apply its proprietary…

Shire and Rani Therapeutics, a San Jose, California-based company specializing in the oral delivery of large-drug molecules, have agreed to conduct research on the use of Rani’s pill technology for…

Otsuka Pharmaceutical and Science 37, a Los Angeles, California-headquartered company focused on “site-less” clinical trials, have signed a strategic collaboration to support efforts to further digitize Otsuka’s mobile clinical study…

Roche has completed its previously announced sale of its solid-dosage manufacturing facility in Leganés, Spain to Recipharm, a Jordbro, Sweden-headquartered contract development and manufacturing organization. In September 2017, Roche signed…

Ardelyx, a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, and Kyowa Hakko Kirin, a Japan-based pharmaceutical company, have signed a license agreement that provides Kyowa Hakko Kirin with…

Pfizer and Basilea Pharmaceutica, a Swiss biopharmaceutical company specializing in anti-infective and oncological medicines, have signed an agreement to grant Pfizer the exclusive development and commercialization rights for Basilea’s Cresemba…